Efforts are afoot to portray the I-91 corridor that
bisects Connecticut and Massachusetts as prime territory for medical
device investment. A report prepared for Hartford, Conn.-based Biomedical
Engineering Alliance &
|
Guidant plans to expand its operations
in Clonmel, Ireland over the next several years and may eventually
add up to
1,000 jobs. |
Consortium (BEACON) concludes the Southern New England corridor has
the necessary infrastructure -- universities, colleges, hospitals, medical
centers and precision manufacturing capabilities -- to grow its already
significant medical device base.
Dr. Joseph Bronzino, BEACON president and professor
of applied science at Hartford's Trinity College, says one of the important
findings of the study is the presence of a large precision manufacturing
industry in the region, with many of those companies broadening their
scope from serving aerospace and defense industries.
"We found that many are already diversifying their
markets and are already doing contract work for the medical device industry
in other areas of the country," Bronzino says.
The I-91 Corridor has more than 100 medical device manufacturers already. Adding in the precision metalworks and plastics manufacturers swells that total to more than 300, Bronzino says.
What's missing is the presence of investment capital to propel startups, Bronzino says. In meetings subsequent to the June 2004 release of the study, BEACON has added recommendations including development of an industry director for the region. The organization also plans to examine what leading states like California are doing to entice and keep startups.
Other sections of New England are also showing
potential. Tiny New Hampshire received the fourth largest amount of
venture capital funding during the first two quarters of 2004, according
to Mark Leahey, executive director of the Medical Device Manufacturers
Association. He says the state is seeing some spillover from Massachusetts,
especially in the Nashua and Manchester areas.